Skip to main content
MedPathMedPath Home
Clinical Trials/EUCTR2016-002032-33-ES
EUCTR2016-002032-33-ES
Active, not recruiting
Phase 1

Comparative study of the efficacy of oral versus intravenous hydration as a preventive measure of contrast-induced nephropathy (CIN) in patients with renal insufficiency (RI) grade III under study conducting Computed Tomography (CT)

Fundacio Privada Clinic per a la Recerca Biomedica0 sitesJuly 15, 2016
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsPatients with renal failure undergoing a computed tomography scan with contrastMedDRA version: 19.0Level: PTClassification code 10038435Term: Renal failureSystem Organ Class: 10038359 - Renal and urinary disordersTherapeutic area: Not possible to specify
DrugsCloruro de sodio Fresenius 9 mg/ml solución para perfusiónBicarbonato Sódico 1/6 M Mein solución para perfusión

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Patients with renal failure undergoing a computed tomography scan with contrast
Sponsor
Fundacio Privada Clinic per a la Recerca Biomedica
Status
Active, not recruiting
Last Updated
9 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
July 15, 2016
End Date
TBD
Last Updated
9 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
All

Investigators

Sponsor
Fundacio Privada Clinic per a la Recerca Biomedica

Eligibility Criteria

Inclusion Criteria

  • •a) Patients of both sexes over 18 years
  • •b) Candidates for a study with computed tomography and intravenous contrast
  • •c) Pesenten a glomerular filtration rate between 30 and 45 mL / min including both determinations
  • •d) They have signed the written informed consent after being informed of the objectives and the nature of the case or be unable to have the authorization or agreement of its representative legally designated for inclusion in the clinical trial
  • •Are the trial subjects under 18? no
  • •Number of subjects for this age range:
  • •F.1\.2 Adults (18\-64 years) yes
  • •F.1\.2\.1 Number of subjects for this age range 350
  • •F.1\.3 Elderly (\>\=65 years) yes
  • •F.1\.3\.1 Number of subjects for this age range 36

Exclusion Criteria

  • •a) refuse to participate in the study
  • •b) Pregnancy or lactation
  • •c) Other risk factors for Contrast Induced Nephropathy:
  • •\- Diabetes mellitus
  • •\- Have an age of 70 years or above
  • •\- Heart failure (defined by a scale New York Heart Association \- NYHA 3 or 4\)
  • •\- Hypotension (defined as systolic blood pressure \<100\)
  • •\- Being treated with nephrotoxic medications.
  • •d) Any disease or a history that, in the investigator's opinion, could confound the results of the study or pose an additional risk to patient treatment.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Not yet recruiting
Phase 2
To study the efficacy of administration of metformin into thyroid nodules and compare it with oral metformin in patients with benign goiter and normal thyroid functioHealth Condition 1: E049- Nontoxic goiter, unspecified
CTRI/2019/07/020053IPGMER
Completed
Phase 1
Comparative study of the effectiveness of oral phenytoibipolar.
IRCT20101130005280N61Mashhad University of Medical Sciences70
Recruiting
Phase 1
Comparative study of the outcome of oral versus nasal intubation in neonates and infants undergoing cardiac surgeryAnaesthesia
PACTR202004476254378Mansoura university children hospital200
Recruiting
Phase 3
Comparison of the effect of COCs and vitamin D-COCs on ovulatory dysfunction Bleeding in reproductive age womeOvulatory dysfunction bleeding.Other specified abnormal uterine and vaginal bleedingN93.8
IRCT20110606006709N22Tabriz University of Medical Sciences60
Completed
Phase 3
Comparison of topical and oral treatments of melasmaMelasma.Chloasma
IRCT201411033566N7Vice chancellor for research, Tabriz University of Medical Sciences90